Specific amacrine cell changes in an induced mouse model of glaucoma

Clinical and Experimental Ophthalmology

Volumn 39, Issue 6, 2011, Pages 555-563

  Gunn, David J ^a   Gole, Glen A ^a   Barnett, Nigel L ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Amacrine cell; Glaucoma; Intraocular pressure (IOP); Mice; Retinal ganglion cell

Indexed keywords

CALRETININ; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; PARVALBUMIN; PROTEIN KINASE C ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; FEMALE; GLAUCOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MOUSE; MUELLER CELL; NICK END LABELING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINA AMACRINE CELL; RETINA GANGLION CELL;

AMACRINE CELLS; ANIMALS; APOPTOSIS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CASPASE 3; DISEASE MODELS, ANIMAL; FEMALE; GLAUCOMA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PARVALBUMINS; PROTEIN KINASE C-ALPHA; RETINAL GANGLION CELLS;

EID: 79961211414     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02488.x     Document Type: Article

References (51)

1. Resnikoff S, Pascolini D, Etya'ale D etal. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-51.
2. Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 2004; 138: S19-31.
3. Weinreb RN, Lindsey JD. The importance of models in glaucoma research. J Glaucoma 2005; 14: 302-4.
4. McKinnon SJ, Schlamp CL, Nickells RW. Mouse models of retinal ganglion cell death and glaucoma. Exp Eye Res 2009; 88: 816-24.
5. Hood DC, Greenstein VC, Holopigian K etal. An attempt to detect glaucomatous damage to the inner retina with the multifocal ERG. Invest Ophthalmol Vis Sci 2000; 41: 1570-9.
6. Raz D, Perlman I, Percicot CL, Lambrou GN, Ofri R. Functional damage to inner and outer retinal cells in experimental glaucoma. Invest Ophthalmol Vis Sci 2003; 44: 3675-84.
7. Bayer AU, Neuhardt T, May AC etal. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci 2001; 42: 1258-65.
8. Fortune B, Bui BV, Morrison JC etal. Selective ganglion cell functional loss in rats with experimental glaucoma. Invest Ophthalmol Vis Sci 2004; 45: 1854-62.
9. Green DG, Kapousta-Bruneau NV. A dissection of the electroretinogram from the isolated rat retina with microelectrodes and drugs. Visual Neurosci 1999; 16: 727-41.
10. Velten IM, Korth M, Horn FK. The a-wave of the dark adapted electroretinogram in glaucomas: are photoreceptors affected? Br J Ophthalmol 2001; 85: 397-402.
11. Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 1998; 17: 485-521.
12. Gur M, Zeevi YY, Bielik M, Neumann E. Changes in the oscillatory potentials of the electroretinogram in glaucoma. Curr Eye Res 1987; 6: 457-66.
13. Moon JI, Kim IB, Gwon JS etal. Changes in retinal neuronal populations in the DBA/2J mouse. Cell Tissue Res 2005; 320: 51-9.
14. Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model. Br J Ophthalmol 2008; 92: 683-8.
15. Arras M, Autenried P, Rettich A, Spaeni D, Rulicke T. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. Comp Med 2001; 51: 443-56.
16. Pease ME, Hammond JC, Quigley HA. Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma 2006; 15: 512-19.
17. Saeki T, Aihara M, Ohashi M, Araie M. The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure - comparison with TonoPen and microneedle manometery. Curr Eye Res 2008; 33: 247-52.
18. Aihara M, Lindsey JD, Weinreb RN. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res 2003; 77: 681-6.
19. Haverkamp S, Ghosh KK, Hirano AA, Wassle H. Immunocytochemical description of five bipolar cell types of the mouse retina. J Comp Neurol 2003; 455: 463-76.
20. Vaquero CF, Velasco A, de la Villa P. Protein kinase C localization in the synaptic terminal of rod bipolar cells. Neuroreport 1996; 7: 2176-80.
21. Verderber L, Johnson W, Mucke L, Sarthy V. Differential regulation of a glial fibrillary acidic protein-LacZ transgene in retinal astrocytes and Muller cells. Invest Ophthalmol Vis Sci 1995; 36: 1137-43.
22. Haverkamp S, Wassle H. Immunocytochemical analysis of the mouse retina. J Comp Neurol 2000; 424: 1-23.
23. Barnett NL, Grozdanic SD. Glutamate transporter localization does not correspond to the temporary functional recovery and late degeneration after acute ocular ischemia in rats. Exp Eye Res 2004; 79: 513-24.
24. Sommer A, Tielsch JM, Katz J etal. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991; 109: 1090-5.
25. Ghosh KK, Bujan S, Haverkamp S, Feigenspan A, Wassle H. Types of bipolar cells in the mouse retina. J Comp Neurol 2004; 469: 70-82.
26. Velten IM, Horn FK, Korth M, Velten K. The b-wave of the dark adapted flash electroretinogram in patients with advanced asymmetrical glaucoma and normal subjects. Br J Ophthalmol 2001; 85: 403-9.
27. Kanis MJ, Lemij HG, Berendschot TT, van de Kraats J, van Norren D. Foveal cone photoreceptor involvement in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2010; 248: 999-1006.
28. Bringmann A, Iandiev I, Pannicke T etal. Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009; 28: 423-51.
29. Sasaoka M, Nakamura K, Shimazawa M, Ito Y, Araie M, Hara H. Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model. Exp Eye Res 2008; 86: 770-82.
30. Woldemussie E, Wijono M, Ruiz G. Muller cell response to laser-induced increase in intraocular pressure in rats. Glia 2004; 47: 109-19.
31. Inman DM, Horner PJ. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007; 55: 942-53.
32. Wang L, Cioffi GA, Cull G, Dong J, Fortune B. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci 2002; 43: 1088-94.
33. Grosche J, Hartig W, Reichenbach A. Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl-2 protooncogene protein by Muller (glial) cells in retinal light damage of rats. Neurosci Lett 1995; 185: 119-22.
34. Erickson PA, Fisher SK, Guerin CJ, Anderson DH, Kaska DD. Glial fibrillary acidic protein increases in Muller cells after retinal detachment. Exp Eye Res 1987; 44: 37-48.
35. Napper GA, Pianta MJ, Kalloniatis M. Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions. Vis Neurosci 1999; 16: 149-58.
36. Savagian CA, Dubielzig RR, Nork TM. Comparison of the distribution of glial fibrillary acidic protein, heat shock protein 60, and hypoxia-inducible factor-1alpha in retinas from glaucomatous and normal canine eyes. Am J Vet Res 2008; 69: 265-72.
37. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992; 15: 303-8.
38. Akopian A, Witkovsky P. Calcium and retinal function. Mol Neurobiol 2002; 25: 113-32.
39. Kim TJ, Jeon CJ. Morphological classification of parvalbumin-containing retinal ganglion cells in mouse: single-cell injection after immunocytochemistry. Invest Ophthalmol Vis Sci 2006; 47: 2757-64.
40. Lee ES, Lee JY, Jeon CJ. Types and density of calretinin-containing retinal ganglion cells in mouse. Neurosci Res 2010; 66: 141-50.
41. May CA, Nakamura K, Fujiyama F, Yanagawa Y. Quantification and characterization of GABA-ergic amacrine cells in the retina of GAD67-GFP knock-in mice. Acta Ophthalmol 2008; 86: 395-400.
42. Kielczewski JL, Pease ME, Quigley HA. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci 2005; 46: 3188-96.
43. Hernandez M, Rodriguez FD, Sharma SC, Vecino E. Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure. Mol Vis 2009; 15: 2696-709.
44. Moroni F, Lombardi G, Pellegrini-Faussone S. Photochemically-induced lesion of the rat retina: a quantitative model for the evaluation of ischemia-induced retinal damage. Vision Res 1993; 33: 1887-91.
45. Frishman LJ, Shen FF, Du L etal. The scotopic electroretinogram of macaque after retinal ganglion cell loss from experimental glaucoma. Invest Ophthalmol Vis Sci 1996; 37: 125-41.
46. Barnett NL, Osborne NN. Redistribution of GABA immunoreactivity following central retinal artery occlusion. Brain Res 1995; 677: 337-40.
47. Osborne NN, Larsen A, Barnett NL, Wood JP, Cazevielle C. Use of immunohistochemistry to follow the localisation of GABA during retinal ischaemia. In: Kato S, Osborne NN, Tamai M, eds. Retinal Degeneration and Regeneration: Proceedings of An International Symposium, Kanazawa, Japan, July 8-9, 1995. Amsterdam, New York: Kugler Publications, 1996; 23-9.
48. Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. The effects of acute intraocular pressure elevation on rat retinal glutamate transport. Acta Ophthalmol 2008; 86: 408-14.
49. Osborne NN, Chidlow G, Wood JP. Glutamate excitotoxicity in glaucoma: truth or fiction? By AJ Lotery. Eye (Lond) 2006; 20: 1392-4.
50. Osborne NN, Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem Int 1996; 29: 263-70.
51. Sun D, Kalloniatis M. Mapping glutamate responses in immunocytochemically identified neurons of the mouse retina. J Comp Neurol 2006; 494: 686-703.